Vertex Pharmaceuticals Inc
F:VX1
Shareholder Yield
Current shareholder yield for 
VX1 is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
VX1 Price
Vertex Pharmaceuticals Inc
| Average Annual Return | 22.98% |
| Standard Deviation of Annual Returns | 18% |
| Max Drawdown | -35% |
| Market Capitalization | 124.5B EUR |
| Shares Outstanding | 258 296 249 |
| Percentage of Shares Shorted |
N/A
|
VX1 Return Decomposition
Main factors of price return
Stock Splits
VX1's latest stock split occurred on Aug 24, 2000
The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.
The adjusted shares began trading on Aug 24, 2000. This was the only stock split in VX1's history.
